Prelude Capital Management, LLC Personalis, Inc. Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.78 - $3.64 $6,052 - $12,376	-3,400 Reduced 21.97%	12,074 $23,000
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $15,525 - $28,579	5,372 Added 53.18%	15,474 $46,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $33,033 - $88,493	10,102 New	10,102 $35,000
Q4 2020 Feb 16, 2021	SELL	$21.84 - $44.0 $6,552 - $13,200	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.63 - $24.12 $4,089 - $7,236	300 New	300 $7,000
Q1 2020 May 15, 2020	SELL	$4.75 - $12.41 $40,427 - $105,621	-8,511 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.73 - $12.95 $45,780 - $67,909	5,244 Added 160.51%	8,511 $93,000
Q3 2019 Nov 14, 2019	BUY	$14.16 - $25.34 $46,260 - $82,785	3,267 New	3,267 $48,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $180M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.